Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Prophylactic Vs Preemptive Valganciclovir

This study has been completed.
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by:
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT00374686
First received: September 7, 2006
Last updated: NA
Last verified: September 2005
History: No changes posted